Brain Cancer News

Oncophage ® Cancer Vaccine Shows Promise Against Glioblastoma (November 4, 2009)

Among patients with recurrent or progressive, high-grade glioblastoma, treatment with the investigational Oncophage® (vitespen) cancer vaccine may improve survival. Preliminary results from a Phase II clinical trial were presented at the 2009 Joint Meeting... Continue Reading

Avastin Active Against Recurrent Glioblastoma (October 13, 2009)

Treatment with the targeted therapy Avastin® (bevacizumab), either alone or in combination with the chemotherapy drug Camptosar® (irinotecan), appears to improve outcomes among patients with recurrent glioblastoma. The results of this Phase II clinical... Continue Reading

Temodar® plus Radiation Improves Survival for Brain Cancer (March 31, 2009)

Radiation therapy plus chemotherapy with Temodar® (temozolomide) improves survival in patients with glioblastoma; almost 10% of patients treated with the combination therapy were alive after five years, compared with 2% of patients treated with radiation... Continue Reading

Ted Kennedy’s Recent Diagnosis of Glioblastoma Raises Awareness of Brain Cancer (March 8, 2009)

Ted Kennedy’s Recent Diagnosis of Glioblastoma Raises Awareness of Brain Cancer Understanding this complex disease and its treatment options By Linda M. Liau, MD, PhD and Charles H. Weaver, MD The recent diagnosis of Ted Kennedy with brain cancer... Continue Reading

Tarceva® and Temodar® plus Radiation Improves Survival in Glioblastoma Multiforme (February 11, 2009)

Tarceva® and Temodar® plus Radiation Improves Survival in Glioblastoma Multiforme The addition of Tarceva® (erlotinib) and Temodar® (temozolomide) during and after radiation therapy improves survival in patients with newly diagnosed glioblastoma multiforme... Continue Reading

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme (October 1, 2008)

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme For the first time ever, the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors has issued treatment guidelines... Continue Reading

Cell Phone Use Does Not Increase Risk of Developing Meningioma Brain Cancer (September 26, 2008)

Cell Phone Use Does Not Increase Risk of Developing Meningioma Brain Cancer Researchers from Finland, Denmark, the United Kingdom, Sweden, and Norway have reported that long-term data do not indicate an association between the use of cell phones and an... Continue Reading

Rituxan® May Be Effective in Central Nervous System Lymphomas (September 11, 2008)

Rituxan® May Be Effective in Central Nervous System Lymphomas Rituxan® (rituximab) may be effective in the treatment of lymphoma that affects the brain and spinal cord (central nervous system). These results were recently presented at the 2008 annual... Continue Reading

Novel Vaccine May Improve Survival in Brain Cancer (June 5, 2008)

Novel Vaccine May Improve Survival in Brain Cancer An investigative vaccine known as CDX-110 may improve survival for patients with glioblastoma multiforme (GBM), a form of brain cancer. These results were recently presented at the 2008 annual meeting... Continue Reading

Avastin® Improves Survival in Recurrent Brain Cancer (June 4, 2008)

Avastin® Improves Survival in Recurrent Brain Cancer Patients with recurrent glioblastoma (a form of brain cancer) who were treated with Avastin® (bevacizumab) alone experienced a slight survival advantage compared with patients treated with Avastin... Continue Reading